Medication & Safety
Return and Refund Policy: What to Check Before You Buy
A clear return and refund policy tells you a lot about a seller before anything goes wrong. Here is what to check before...
Saxenda is a daily injection that helps you eat less by acting on the same hunger pathway your gut uses naturally. It contains liraglutide, a GLP-1 medication approved for weight management in adults. If you have been researching weight loss injections, Saxenda is often the first name you meet, and it works quite differently from the weekly injections that get more attention today.
This guide covers what Saxenda is, how it works in your body, what results the clinical trials recorded, and what the practical options look like if you are in Pakistan.
What Saxenda actually is
Saxenda is the brand name for liraglutide at a 3.0 mg dose. Liraglutide is a synthetic version of GLP-1 (glucagon-like peptide-1, a hormone your small intestine releases after you eat). Your body makes this hormone naturally. It tells your brain you have eaten enough.
The problem is that natural GLP-1 breaks down within minutes. Liraglutide is built to survive much longer, so the fullness signal keeps working through the day.
Saxenda comes as a pre-filled pen. You inject it under the skin of your stomach, thigh or upper arm once every day.
The same drug is sold as Victoza at lower doses of 1.2 mg and 1.8 mg for type 2 diabetes. Same molecule, different dose, different approved use.
How Saxenda works in your body
Saxenda acts in three places at once.
In your brain. It reaches the appetite control centres in the hypothalamus and reduces hunger signalling. Most people describe this as food simply mattering less. The constant mental pull toward snacks quietens down.
In your stomach. It slows gastric emptying, which means food stays in your stomach longer. You feel full sooner during a meal and stay full for longer afterwards.
In your pancreas. It increases insulin release when your blood sugar is high and lowers glucagon, a hormone that raises blood sugar. This is why the lower-dose version treats diabetes.
The combined effect is that you eat less without constantly fighting the urge to eat more. That distinction matters. Willpower-based dieting fails for most people because hunger eventually wins. GLP-1 medications change the hunger itself.
What results the trials recorded
The main evidence comes from the SCALE Obesity and Prediabetes trial, published in the New England Journal of Medicine in 2015. It followed 3,731 adults without type 2 diabetes for 56 weeks.
People taking liraglutide 3.0 mg lost an average of 8.4 kg. The placebo group lost 2.8 kg. That is a genuine difference of roughly 5.6 kg attributable to the drug itself.
Put another way, that is about 8 percent of starting body weight. It is meaningful, and it is enough to improve blood pressure, blood sugar and cholesterol in most people who achieve it.
It is also notably less than the newer weekly medications produce. In the STEP 8 trial, published in JAMA in 2022, weekly semaglutide produced substantially more weight loss than daily liraglutide over 68 weeks in a direct head-to-head comparison.
How you take it
Saxenda starts low and builds up over five weeks. This is called titration, and skipping it causes most of the severe nausea people report.
- Week 1: 0.6 mg daily
- Week 2: 1.2 mg daily
- Week 3: 1.8 mg daily
- Week 4: 2.4 mg daily
- Week 5 onward: 3.0 mg daily
You inject at roughly the same time each day. It does not need to be with food. The pen is stored in the fridge before first use, then kept at room temperature for up to 30 days.
If you have not lost at least 4 percent of your starting weight after 16 weeks at the full dose, the guidance is to stop. Some people simply do not respond to this pathway.
Side effects you should know about
Nausea is the most common complaint, and it affects roughly four in ten users. It is usually worst in the first few weeks and settles as your body adapts.
Other frequent effects include vomiting, diarrhoea, constipation, headache and fatigue. Most are mild and dose-related, which is exactly why the five-week build-up exists.
More serious but far less common risks include pancreatitis (inflammation of the pancreas) and gallbladder problems. Rapid weight loss of any kind raises gallstone risk.
Saxenda is not suitable if you have a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. It is also not used during pregnancy or breastfeeding.
The daily injection problem
Here is the practical issue that trial data does not capture well. Saxenda requires 365 injections a year.
Real-world discontinuation rates for daily GLP-1 injections are high. People manage the first month, then the daily routine wears them down. Missing doses undermines the steady appetite suppression the drug depends on.
This is the single biggest reason weekly medications overtook Saxenda in popularity. One injection a week is simply easier to sustain than seven.
What this means in Pakistan
Saxenda has limited and inconsistent availability in Pakistan. When it can be found, it is imported, expensive, and requires refrigerated storage plus a prescription. Supply gaps are common, and an interrupted GLP-1 course loses much of its benefit.
That access gap is why sublingual GLP-1 support without injections has become the route many Pakistani adults take instead. METASLIM™ is a physician-reviewed GLP-1 sublingual supplement, held under the tongue rather than injected, with a physician reviewing every order before it ships. It works on the same GLP-1 appetite pathway without the daily needle, the cold chain, or the import dependency.
Before you consider any weight management medication, calculate your BMI so you know your actual starting point. Most GLP-1 options are intended for adults with a BMI of 27 or above with a weight-related condition, or 30 and above generally.
For a broader view of the field, our guide to Ozempic alternatives compares every major option side by side, and the Pakistan access guide covers what is realistically obtainable here.
Is Saxenda worth considering
Saxenda works. The mechanism is sound and the trial evidence is solid. For someone who has access to it, tolerates it, and can commit to a daily injection, it produces real and clinically useful weight loss.
For most people weighing their options today, the weekly medications produce more weight loss with fewer injections. And for people in Pakistan, availability is the deciding factor more often than efficacy.
If you are choosing between options, see if you qualify for the program that fits your situation and budget rather than chasing whichever drug is most talked about.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before starting any weight loss program, medication, or supplement.